United-Guardian Reports Second Quarter Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
United-Guardian Reports Second Quarter Financial Results

HAUPPAUGE, N.Y., Aug. 09, 2016 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ: UG ) today reported second quarter net income of $405,381 ($0.09 per share) on sales of $2,139,165, and net income of $930,472 ($0.20 per share) on sales of $4,401,741 for the first half of 2016. The decreases from last year’s second quarter and first half were not unexpected based upon previous information that had been released by the company.

Ken Globus, President of United-Guardian, stated, "As expected, second quarter sales continued to lag behind last year’s comparable quarter due to slow sales in China, where our distributor is still working off excess inventory brought in during the first nine months of 2015. That overstock situation was the result of overly optimistic projections it had received from its Chinese customers, along with a regulatory issue unrelated to our product that required customers to reformulate their products, a process that is ongoing. As a result, we did not expect sales of our personal care products in China to pick up until the second half of this year, and that is reflected in the second quarter sales numbers. Our marketing partner in China has informed us that sales are expected to resume by the end of the third quarter or beginning of the fourth.”

“On a more positive note,” continued Mr. Globus, “sales of our new Renacidin ® 30mL bottle have increased dramatically since we began selling the product in April, and have surpassed our expectations. Revenue from the new Renacidin in June was approximately $280,000, more than double the $130,000 a month we were averaging for the old Renacidin, and in July revenue jumped to $340,000. We are very excited about this, and are optimistic that sales will reach the levels that we had hoped for when we decided to bring this new, more convenient single-dose package to market. With increasing Renacidin sales, along with our expectation that purchases of our personal care products for the Chinese market will resume in the second half of the year, we are optimistic that sales and earnings will increase as the year progresses. We continue to be profitable and are confident that we will be able to continue to pay a year-end cash dividend as we have for the past 21 years.”

United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, pharmaceuticals, and specialty industrial products.

NOTE: This press release contains both historical and "forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company’s expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the “safe harbor” provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company’s business please refer to the company's reports and filings with the Securities and Exchange Commission.

 
RESULTS FOR THE THREE AND SIX MONTHS ENDED
JUNE 30, 2016 and 2015
 
STATEMENTS OF INCOME (UNAUDITED)
 
    THREE MONTHS ENDED JUNE 30,       SIX MONTHS ENDED JUNE 30,  
    2016     2015       2016     2015  
                           
Net sales $ 2,139,165   $ 4,124,091     $ 4,401,741   $ 8,496,484  
                           
Costs and expenses:                          
Cost of sales   1,007,666     1,403,942       1,905,391     3,083,144  
Operating expenses   465,329       443,991       932,885     904,918  
Research and development     157,895       156,541         335,461       322,849  
Total costs and expenses   1,630,890     2,004,474       3,173,737     4,310,911  
   Income from operations     508,275     2,119,617       1,228,004     4,185,573  
                           
Investment income    82,906       72,894         126,218       126,348  
   Income before income taxes   591,181     2,192,511       1,354,222     4,311,921  
                           
Provision for income taxes   185,800       682,000       423,750     1,340,900  
   Net Income $ 405,381   $ 1,510,511     $ 930,472   $ 2,971,021  
                           
Earnings per common share  (Basic and Diluted)   $            .09   $         0.33     $        0.20   $          0.65  
                           
Weighted average shares – basic and diluted   4,594,319     4,596,439       4,594,319     4,596,439  
                           

••• Additional financial information can be found at the company’s web site at www.u-g.com . •••

Contact: Robert S. Rubinger Public Relations (631) 273-0900

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Egan-Jones Backs DGB's Push for Ethan Allen Shakeup

Updated Category News Views 59

Proxy Fight Brews Over Ethan Allen's Future Here we are, embroiled in another classic showdown in the corporate boardroom, and this time it's over at Ethan Allen—home of those plush couches and dining tables. Egan-Jones proxy services just threw its weight behind all five of DGB Investment's nominees for Ethan Allen’s board. This kind of tug-of-war isn't new, but each...

Continue Reading
Miraculous Medical Team Effort Saves Newborn's Life

Updated Category News Views 4

A Medical Feat: Teamwork at Its Pinnacle You want a story that restores your faith in humanity? Well, this one from Memorial Healthcare System and Joe DiMaggio Children's Hospital might just do the trick. The tale of baby Jay'ce, born with a neck mass threatening his breath, is straight out of a medical drama—albeit without the Hollywood scriptwriters' spin. It’s rare...

Continue Reading
Ares Commercial Real Estate Gears Up for Q3 Earnings

Updated Category News Views 21

Earnings Season Descends on Ares Commercial Real Estate The hush before the storm is here, comrades. Ares Commercial Real Estate Corporation (NYSE: ACRE) has set the ticker tape rolling as they prepare to unveil the fiscal secrets of their third quarter on November 6, 2026. If you’ve got skin in the game or just an ear for market music, mark your calendars because the...

Continue Reading
Tragedy in Jordan: A Call for Unity and Support

Updated Category News Views 8

A Dark Day in Jordan It's a gut punch, hearing news of yet another brutal attack targeting the Christian community in Jordan's Karak province. This act of terror isn't just a regional dagger—it cuts deep into the fabric of shared humanity. On Friday, the tranquil air of a sacred gathering was shattered, leaving behind grief and a call to action for those who refuse to...

Continue Reading
S&P Global's New Dashboard: Unpacking Data Insights

Updated Category News Views 32

An Interactive Take on Digital Infrastructure The geniuses over at S&P Global Ratings have just unleashed a shiny new tool for number crunchers and market hawks who can't get enough data center action—an interactive dashboard. Maybe not everyone’s cup of tea, but hey, in the dog-eat-dog world of digital infrastructure, any edge counts. What's in the Data Center Soup?...

Continue Reading
Cowfest 2026 Delighted by Frederick's Flying Cows

Updated Category News Views 40

Moo-ving Towards a New Record Alright, listen up. This fall, there's a bovine spectacle coming to Maryland that's more than just a trip down to the fairgrounds—it's Cowfest 2026, baby! Now, if you're scratching your head thinking this is just another seasonal shindig, you're underestimating what's mooing across Frederick County. The Flying Cows are ready to take the...

Continue Reading
Qatar's Cultural Ventures Go Big Through 2030

Updated Category News Views 6

Cultural Partners Lined Up Well Ahead In the swirling world of cultural diplomacy, Qatar's got its eyes set way beyond the skyline with their Years of Culture initiative. Announced recently, they've lined up partners through 2030, locking hands with Italy, the Netherlands, Switzerland, Portugal, and Spain in the coming years. Such moves aren't just for show—they’re...

Continue Reading
Ractigen's LiCO™ Platform Hits Extrahepatic Milestones

Updated Category News Views 52

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

Continue Reading
University of Phoenix Unveils Credit for Prior Learning Advantages

Updated Category News Views 27

Navigating College Credits with Life Experience If you think school is the only place to pick up education that counts, think again. University of Phoenix is challenging this by recognizing the value of the hustle and grind working adults go through. During the recently wrapped-up National Transfer Student Week, Devin Andrews, their VP of Admissions and Evaluation, shed...

Continue Reading
Italian Excellence: NYC Celebrates Innovators and Icons

Updated Category News Views 95

The Fusion of Italian Artistry and Innovation Imagine blending business savvy with a touch of culture and ethics. That's the spirit of the 9th Business Care International Award, which is gearing up to hit New York City's grand stage come November 18-19. This ain't just about pats on the back; it's a recognition of those who push Italian excellence across oceans and into...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Investigation: Crocs Investors Urged to Act Now

Updated Category News Views 109

Investors Encouraged to Take Action Regarding Crocs Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson encourages investors who suffered losses exceeding $100,000 in Crocs to contact him directly to discuss their options. If you have experienced losses of over $100,000 related to Crocs during recent financial periods, calling Faruqi & Faruqi might...

Continue Reading
Exploring the Impact of .lunar Domains on Space Ventures

Updated Category News Views 120

Unveiling the .lunar Domain Extension Unstoppable Domains and Copernic Space have made waves with their groundbreaking initiative involving the launch of the .lunar domain extension. This innovative top-level domain is designed specifically for trailblazers exploring the realms of space, cryptocurrencies, and decentralized physical infrastructure networks (DePIN). By...

Continue Reading
Investigation Launched for Investors in Dave Inc. - DAVE

Updated Category News Views 297

Investigation Overview for Dave Inc. Investors Pomerantz LLP is currently conducting an investigation aimed at protecting the interests of investors in Dave Inc. (NASDAQ: DAVE). Investors concerned about the validity of their investments or those seeking to understand more about potential corporate misconduct are encouraged to reach out. Key Allegations Against Dave Inc....

Continue Reading
Innovative Solutions Unveiled at Safety Pharmacology Society Meeting

Updated Category News Views 51

Exciting Innovations from Harvard Bioscience Harvard Bioscience, Inc. (NASDAQ: HBIO) is gearing up to present a variety of groundbreaking products at an important annual gathering tailored for safety pharmacologists. The company is dedicated to advancing life sciences and has crafted solutions that meet the varied needs of researchers and developers in the pharmaceutical...

Continue Reading
Upcoming Earnings Report for Cinemark Holdings Inc.

Updated Category News Views 138

Key Insights Ahead of Cinemark's Earnings Release Cinemark Hldgs (CNK) is gearing up to unveil their quarterly earnings report. Investors are buzzing with anticipation, keen to see how the company measures up against analyst expectations. Analysts are predicting an earnings per share (EPS) of $0.76, a number that reflects optimistic sentiment surrounding the company's...

Continue Reading